Yu, Ruixuan
Zheng, Ruiqiang
Chen, Xufeng
Zhao, Huiying
Jin, Jun
Wang, Changsong
Xiang, Shulin
Huang, Man
Zhao, Hongsheng
Wang, Yi
Shi, Nan
Chen, Hui
Yang, Yi
Xie, Jianfeng
Qiu, Haibo
Funding for this research was provided by:
National Natural Science Foundation of China (82402565)
National Natural Science Foundation of China (82341032)
National Key Research and Development Program of China (2022YFC2504405)
Jiangsu Provincial Key Research and Development Program (BE2023602)
Noncommunicable Chronic Diseases-National Science and Technology Major Project (2023ZD0506506)
Noncommunicable Chronic Diseases-National Science and Technology Major Project (2023ZD0506500)
Article History
Received: 8 January 2026
Accepted: 26 February 2026
First Online: 5 March 2026
Declarations
:
: This study was approved by the Clinical Research Ethics Committee of the Affiliated Zhongda Hospital, Southeast University (2023ZDKYSB003) and the Ethics Committee of Jin Yin-tan Hospital (KY-2020-10.02). Given its observational design, the study did not involve any medical, pharmacological, or behavioral interventions in addition to standard protocols used in physicians practice, regardless of the registry. Due to the retrospective nature of the study and the use of anonymized patient data, the requirement for written informed consent was waived. Research has been carried out and data concerning patient consent were handled in agreement with the principles laid out in the original Declaration of Helsinki and its later amendments.
: Not applicable.
: All authors have read the manuscript and consented for publication.
: The authors declare no competing interests.